News

PSE: New Technology Has Potential to Transform Pharma Manufacture
LONDON--(BUSINESS WIRE)--Leading pharmaceuticals company Pfizer outlined its vision for Systems-based Pharmaceutics at the recent Advanced Process Modelling Forum in London organised by Process Systems Enterprise (PSE)

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Newron Pharmaceuticals PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed
Newron Pharmaceuticals S.p.A. (Newron), a research and development company focused on novel CNS and pain therapies announces that it has executed with Zambon, the Italian chemical and pharmaceutical Company (Zambon), a strategic collaboration and licence agreement for Newrons lead compound safinamide. In aggregate, the total Zambon investment in Newron will be 20m as defined below, also covering...

Takeda Pharmaceutical Co. Ltd. Open to More M&A Deals
After spending nearly $15 billion on overseas acquisitions in less than two years, Japan's top drug maker Takeda Pharmaceutical Co. is not ruling out further deals as it looks to overcome patent expiries and cement its position as a global industry player. "We will be looking for those things that are a very good fit with what we have already put in place," Anna Protopapas, a corporate officer at...

Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
SAN DIEGO, May 16, 2012 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a pharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today positive results from a Phase 2b study of EP-101 in patients with chronic obstructive pulmonary disease (COPD), a progressive disease comprising chronic bronchitis...

Ra Pharmaceuticals Closes $8.6 Million Second Tranche of $27 Million Series A
Cambridge, MA, May 16, 2012 Ra Pharmaceuticals today announced it is pursuing hereditary angioedema (HAE) as a lead program, leveraging the Companys proprietary Cyclomimetic drug discovery and development platform. HAE is a rare, but serious and often fatal disorder of the innate immune system that causes intermittent attacks characterized by swelling and pain of the face, airways and intestinal...

Massachusetts Life Sciences Center Release: Breaks Ground on First in the Nation Biomanufacturing Center; Creating 10 Permanent Jobs
FALL RIVER Wednesday, May 16, 2012 Governor Deval Patrick today broke ground on the $28 million Massachusetts Accelerator for Biomanufacturing (MAB) at the University of Massachusetts Dartmouth. The facility, a result of Governor Patrick's $1 billion Life Sciences Initiative, is expected to create 120 construction jobs and ten permanent jobs and strengthen Massachusetts' standing as a world leader...

AstraZeneca PLC Slashes 400 More Jobs in Sweden
Another 400 jobs will be cut from Anglo-Swedish pharmaceutical manufacturer Astra Zeneca, the company has announced, with the majority of the redundancies in Sdertlje, south of Stockholm. According to the company this is an implementation of the cuts that the company presented in February, when the company announced that 1,100 employees would have to go. We realized already then that it was administrative...

Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer Inc., AstraZeneca PLC, Sanofi (France)
Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc. (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the drugmakers sale process, said people familiar with the matter. Merck & Co., Takeda Pharmaceutical Co., Roche Holding AG (ROG) and Bristol-Myers Squibb Co. (BMY) also signed agreements to get access to confidential financial and product information...

GlaxoSmithKline to Fully Buy Cellzome AG for $99 Million
Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSK.LN) said Tuesday it has entered into an agreement to buy the 80.02% of Cellzome AG it doesn't already own for GBP61 million in cash. Cellzome, a privately owned company with laboratories in Cambridge, U.K., and Heidelberg, Germany, will become part of GSK's R&D organization. Cellzome's proteomics technologies can be used...

Achillion Pharmaceuticals, Inc.'s Hepatitis C Drug Gets FDA Fast Track
NEW HAVEN, Conn., May 15, 2012 (GlobeNewswire via COMTEX) -- Achillion Pharmaceuticals, Inc. /quotes/zigman/100395/quotes/nls/achn ACHN 2.32% announced today the receipt of a Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACH-3102 as part of an interferon-free regimen for the treatment of chronic hepatitis C (HCV). ACH-3102 is a pan-genotypic second-generation NS5A inhibitor...

Scil Proteins GmbH, Ono Pharmaceutical Company, Ltd. Establish Affilin Therapeutics Discovery and Development Collaboration
HALLE, Germany--(BUSINESS WIRE)-- Scil Proteins GmbH, a private biotech company specializing in the research, development and production of recombinant proteins, today announced that it has signed a collaboration agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan), for the joint discovery and development of new Affilin therapeutics to treat various diseases. Initially, Scil Proteins will identify...

Promedior Moves Fibrosis Pipeline to Boston, Hires Shire plc Vet as CEO
MALVERN, Penn., May 15, 2012 (BUSINESS WIRE) -- --Company to Relocate Headquarters to Boston Area Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced the appointment of Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer. Dr. Bruhn takes on the role of CEO at a time when Promedior is rapidly advancing...

Watson Pharmaceuticals, Inc. Shuts Down Groveport Warehouse, Lays Off 55
Business First by Rick Rouan, Web coordinator

A New Jersey pharmaceutical company plans to lay off 55 Central Ohio employees this summer as it prepares to move its Groveport distribution center to Mississippi.

Anda Inc., a distribution subsidiary of Parsippany, N.J.-based Watson Pharmaceuticals Inc. (NYSE:WPI), will release the employees around July 5, according to a layoff notice...


Furiex Pharmaceuticals, Inc. Says Johnson & Johnson Returns Sexual Dysfunction Drug Rights
Furiex Pharmaceuticals Inc said its partner Johnson & Johnson returned the worldwide rights for its oral drug to treat premature ejaculation. Furiex said it has licensed the rights of the drug to European pharmaceutical company Menarini in Europe, most of Asia, Africa, Latin America and the Middle East for $15 million in cash. Furiex will also get up to $60 million if the drug clears certain regulatory...

Takeda Pharmaceutical Co. Ltd. Phase III Crohn's Disease Trial Meets Primary Endpoints
Takeda Pharmaceutical Company has announced that GEMINI II pivotal Phase III trial of vedolizumab in moderately to severely active Crohn's disease patients has met primary endpoints. The trial evaluated vedolizumab in 1,115 Crohn's disease patients who have failed at least one conventional therapy, including TNFa antagonists. Takeda General Medicine (Gastrointestinal and Genitourinary) vice president...

Ventrus Biosciences, Inc. Unveils Positive Results of Its Phase 3 Trial of Diltiazem
NEW YORK, May 14, 2012 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS - News) today reported positive results from its Phase 3, randomized, double-blind, placebo-controlled clinical trial of diltiazem hydrochloride cream (VEN 307) in patients with anal fissures. Ventrus' development partner, S.L.A. Pharma, has completed most of the outputs for the statistical analysis plan of the Phase...

Bristol-Myers Squibb Company and Tsinghua University Enter Strategic Partnership
PRINCETON, N.J. & BEIJING, China--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY - News) and Tsinghua University of Beijing, China, today announced the formation of a multi-year strategic partnership.

Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua Universitys School of Life Sciences to identify and validate novel targets in oncology and immunoscience...


OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO
San Francisco Business Times by Ron Leuty, Reporter

OncoMed Pharmaceuticals Inc. is seeking $115 million in an initial public stock offering, the company said Friday.

The Redwood City-based cancer drug developer, one of the most successful Bay Area biotech companies at raising venture capital over the past five years, said it will use proceeds of the IPO to advance its lead drug...


Opko Health, Inc. Catches Investors' Attention With Alzheimer's Test
As Pfizers rheumatoid arthritis pill and Arena Pharmaceuticals weight-loss drug got positive nods from federal advisory panels, the role of biotech companies in finding new treatments for major medical disorders is getting renewed investor attention. An advisory group at the Food and Drug Administration recommended approval of Pfizers drug, known as tofacitinib, which could possibly revive sales...

Arena Pharmaceuticals, Inc. Wins Positive FDA Panel Vote for Obesity Drug
WOODCLIFF LAKE, N.J., May 10, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks...

Inside the Secret World of Drug Company Rebates
The free market is alive and well when it comes to drug prices if youre an insurance company or a government program. But not if youre a consumer. Top-selling pharmaceuticals, protected by patents, often seem priced in a manner that has little to do with the laws of supply and demand. Want that new cholesterol medicine ($2,000 per year), that cancer treatment ($60,000 per year) , or the medicine...

PolyMedix Inc. Stops Studies on Anti-coagulant Reversing Agent
RADNOR, Pa., May 10, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat patients with serious acute-care conditions, today announced an update on the development status of its anticoagulant reversing agent, PMX-60056. PolyMedix has stopped enrollment in two clinical trials for PMX-60056: a Phase 2 clinical trial...

Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct
Rib-X Pharmaceuticals Inc., an antibiotic developer based in New Haven, Conn., on Wednesday morning postponed its anticipated IPO only one day after it cut the price about 50 percent, according to information from the Nasdaq OMX Group Inc. citing Renaissance Capital. The company did not return calls for comment. A source close to the company confirmed that the IPO was postponed because of market conditions...

Arena Pharmaceuticals, Inc. and Eisai Inc. Expand Marketing and Supply Agreement for Lorcaserin
WOODCLIFF LAKE, N.J., May 10, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today the expansion of the lorcaserin marketing and supply agreement between Arena Pharmaceuticals, Inc.'s wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Eisai Inc. Lorcaserin is an investigational drug candidate intended for weight management...

Oxford Finance Provides $27.5 Million Debt Financing Facility to Pacira Pharmaceuticals, Inc.
ALEXANDRIA, Va., May 10, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $27.5 million senior secured term loan with Pacira Pharmaceuticals ("Pacira"). Proceeds of the loan are being used to refinance...

Onconova Therapeutics Inc. Drug Developer Raises $7 Million in Financing
Philadelphia Business Journal by John George, Senior Reporter

Onconova Therapeutics raised $7.05 million in a private equity financing, according to documents filed with the Securities and Exchange Commission.

The indentities of the investors were not disclosed.

The Newtown, Pa., biotechnology company is seeking to raise a total of $30 million.

Onconova is developing...


AMAG Pharmaceuticals, Inc. Slumps as it Shelves Possible Sale
Shares of Amag Pharmaceuticals Inc. sank Thursday, a day after the anemia drug maker said it is no longer considering selling itself. THE SPARK: Amag said it has decided to focus on improving sales of its drug Feraheme. The company said in November it had hired Jefferies & Co. to evaluate options for the company, including a possible sale. On Wednesday, Amag said it named William Heiden as its new...

Eli Lilly and Company and Abbott Laboratories Win Big in Sales Rep Overtime Case
In a decision that bolsters the pharmaceutical industry, a federal appeals court has ruled that sales reps are not eligible for overtime pay. In doing so, the court also rejected the position taken by the US Department of Labor, which has filed briefs in numerous cases supporting the notion that sales reps are entitled to overtime. The ruling by the Seventh Circuit Court of Appeals combined cases involving...

Lipitor Clone Lifts Ranbaxy Laboratories While Pfizer Inc. Bids Drug Goodbye
Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the same time, generic drug manufacturer Ranbaxy posted record revenue for the last business quarter, growth fueled largely by sales of generic atorvastatin in the United States.

Takeda Pharmaceutical Co. Ltd. Reports Top-line Results From GEMINI II Pivotal Phase 3 Trial
OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohns disease who have failed at least one conventional therapy, including TNFa antagonists. Many...

GlaxoSmithKline: We Complied With Indian Rules for Drug Approval
Indias top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials, a parliamentary panel said in a report. The Central Drugs Standard Control Organization which oversees clinical trials and Indias 10,000 drugmakers, approved medicines from companies including Novartis AG (NOVN), GlaxoSmithKline Plc (GSK) and Mumbai-based Cipla...

Dr. Philippe Calais Appointed Chief Executive Officer of ANTISENSE PHARMA GmbH
Regensburg, Germany, May 10, 2012 / B3C newswire / - The biopharmaceutical company Antisense Pharma announces the appointment of Dr. Philippe Calais as CEO. The native-born Frenchman has more than two decades of international experience in executive positions in biotech and pharmaceutical companies including Hofmann La-Roche and ICI Pharmaceuticals and has successfully guided several medicines...

AMAG Pharmaceuticals, Inc. Appoints as President and Chief Executive Officer
LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG - News) today announced the appointment of William K. Heiden as president and chief executive officer, effective May 14, 2012. Mr. Heiden, age 52, has also been appointed to the companys board of directors. AMAG also announced that its largest shareholder, Adage Capital, has requested and the company has agreed to allow Adage...

LaserGen, Inc. Names as CEO
HOUSTON, May 10, 2012 /PRNewswire/ -- Emerging biotechnology company LaserGen, Inc., focused on commercializing novel technologies for next-generation sequencing (NGS), announced the appointment of Mimi Healy, Ph.D. as Chief Executive Officer (CEO) and to the LaserGen Board of Directors.

Dr. Healy brings more than two decades...


RXi Pharmaceuticals Appoints Industry Veteran as President and Chief Executive Officer
WORCESTER, Mass., May 10, 2012 (BUSINESS WIRE) -- RXi Pharmaceuticals Corporation today announced that Geert Cauwenbergh, Dr. Med. Sc. has been appointed as the Company's President and Chief Executive Officer. Dr. Cauwenbergh brings more than 30 years of experience in the pharmaceutical industry, including a successful track record developing and commercializing dermatological drugs. Dr. Cauwenbergh...

GlaxoSmithKline's $2.6 Billion Bid for Human Genome Sciences, Inc. Goes Hostile
GlaxoSmithKline will take its $2.6 billion bid for Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the U.S. biotech group's board. The decision to go hostile with the $13 a share cash tender offer sets GSK up for a potentially lengthy battle with those Human Genome investors who believe it is not offering enough. "They will do fantastically...

Lethal Injection Drug from Naari AG Held by Nebraska is Recalled
A Swiss pharmaceutical company has issued a voluntary recall of a lethal injection drug held by Nebraska, but state officials said Wednesday they won't return the drug and the U.S. Food and Drug Administration says it won't enforce the company's decision. Naari AG asked Nebraska officials to quarantine its supply of sodium thiopental and return it to the company or the FDA. The company said in a recall...

FDA Advisers Reject Regeneron Pharmaceuticals, Inc. Gout Drug
TARRYTOWN, N.Y., May 8, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against approval of ARCALYST (rilonacept) Injection for Subcutaneous Use for the proposed indication for the prevention of gout flares in patients initiating uric acid...

FDA Staff Focus on Safety of Arena Pharmaceuticals, Inc. Obesity Pill
U.S. drug reviewers on Tuesday said Arena Pharmaceuticals Inc's obesity pill appeared to help people lose weight and was unlikely to cause tumors in humans, but questioned if the company had provided enough data to rule out heart problems. Lorcaserin is one of three new potential obesity treatments vying to gain U.S. approval and be the first new weight-loss treatment on the market in over a decade...


Warning: DOMDocument::load(http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.rss) [domdocument.load]: failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/techcncl/techcouncilmd.com/news/index.php on line 97

Warning: DOMDocument::load() [domdocument.load]: I/O warning : failed to load external entity "http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.rss" in /home/techcncl/techcouncilmd.com/news/index.php on line 97
Panel of Top Industry Executives to Discuss Biotech and Big Pharma – What’s Next? – 2012 BIO International Convention Keynote
WASHINGTON--(BUSINESS WIRE)--2012 BIO International Convention will feature a panel of top industry executives to discuss where biotech will be in the next ten years and how the pharmaceutical industry landscape is changing.


Consumer Acceptance, Genetically Engineered Agriculture Products and Biotech Crop Development to be the Focus at the 2012 BIO International Convention
WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention looks to give a global perspective on regulatory and acceptance issues within the food and agriculture sector of the biotechnology industry.


Executives, Agency Officials Discuss National Bioeconomy Blueprint
--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.


Executives, Agency Officials Discuss National Bioeconomy Blueprint
--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.


BIO Applauds Senate Agriculture Committee for Passing Bipartisan Farm Bill
WASHINGTON--(BUSINESS WIRE)--BIO thanks Senate Agriculture Committee for passage of Farm Bill, with important programs for the biotechnology industry.


New National Bioeconomy Blueprint Can Help Unleash the Promise of Biotech to Drive American Innovation, Promote Job Growth and Continue U.S. Competitiveness
WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Obama Administration's new National Bioeconomy Blueprint issued today: “BIO applauds President Obama’s leadership in creating a National Bioeconomy Blueprint and identifying the bioeconomy as a priority for his Administration. We appreciate the President’s recognition of the need to clear the path for American innovation and ingenuity and unleash t


Senator Bob Menendez Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Senator Robert Menendez (D-NJ) as a Legislator of the Year for 2011-2012.


Representative Rogers Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Mike Rogers (R-MI) as a Legislator of the Year for 2011-2012.


Representative Kingston Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Jack Kingston (R-GA) as a Legislator of the Year for 2011-2012.


Representative Schwartz Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Allyson Schwartz (D-PA) as a Legislator of the Year for 2011-2012.


Senator Enzi Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Senator Michael Enzi (R-WY) as a Legislator of the Year.


Senator Hagan Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization selected Senator Kay Hagan (D-NC) as a Legislator of the Year for 2011-2012.


BIO Announces Governor Jon Huntsman as Keynote Speaker for the BIO Convention in China
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announces that Governor Jon Huntsman, former U.S. Ambassador to China and Governor of Utah, will provide a keynote address at the BIO Convention in China.


Biotechnology Patenting and Intellectual Property to be Highlighted at 2012 BIO International Convention
WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer.


Leaders in Science, Advocacy to Judge 2012 Biotech Humanitarian Award
WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announced a distinguished panel of judges who will evaluate nominations for the fourth annual Biotech Humanitarian Award and select the 2012 Honoree. BIO created the Award to recognize an everyday hero who has helped to heal, fuel and feed the planet through their work in or support of biotechnology. Nominations for the Award will be accepted online through the April 20, 2012 deadline. “The Biotech Humanitarian Awa


BIO Submits Comments on FDA Draft Guidances on Biosimilars
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products.


Samenvatting: De eerste op windenergie gerichte internationale conferentie in Japan
TOKYO--(BUSINESS WIRE)--Reed Exhibitions Japan heeft de opening gemeld van de Wind Energy Expo & Conference (WIND EXPO) 2013. Het is de eerste conferentie in Japan speciaal gericht op windenergie die wordt gehouden tijdens de World Smart Energy Week 2013, een verzameling van gespecialiseerde conferenties gerelateerd aan hernieuwbare energie. FC EXPO 2013 - 9e Hydrogen & Fuel Cell Expo PV EXPO 2013 - 6e Photovoltaic Power Generation Expo PV SYSTEM EXPO 2013 - 4e Photovoltaic Power Generat

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Research and Markets: Microsoft Project 2010 - Most Up to Date Features
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mhz32d/microsoft_project) has announced the addition of John Wiley and Sons Ltd's new book "Microsoft Project 2010" to their offering. The most up to date features are covered for this latest Microsoft release, Project 2010. You can be certain this book helps you introduce your students to the wide array of new features this powerful, easy-to-use tool offers. Learn about powerful new ways to help your stude

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Research and Markets: Microsoft Windows Operating System Essentials - Full-Color Guide to Key Windows 7 Administration Concepts and Topics
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dkfsh7/microsoft_windows) has announced the addition of John Wiley and Sons Ltd's new book "Microsoft Windows Operating System Essentials" to their offering. A full-color guide to key Windows 7 administration concepts and topics Windows 7 is the leading desktop software, yet it can be a difficult concept to grasp, especially for those new to the field of IT. Microsoft Windows Operating System Essentials is

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Resumen: PSE: la nueva tecnología tiene el potencial de transformar la fabricación farmacéutica
LONDRES--(BUSINESS WIRE)--Pfizer, la empresa farmacéutica líder, ha destacado su visión de Systems-based PharmaceuticsTM, un enfoque revolucionario basado en modelos que une el proceso farmacéutico y la ingeniería de productos con la calidad y el rendimiento de los productos en el cuerpo humano, en el reciente Foro sobre modelado avanzado de procesos celebrado en Londres. Ravi Shanker, socio de investigación senior de Pfizer y ponente destacado, sostuvo que es esencial que las empresas farmacéut

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


PopCap Games Launches Bejeweled® HD for iPad®
DUBLIN--(BUSINESS WIRE)--PopCap launches Bejeweled HD for iPad which is available in English, French, Italian, German and Spanish

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


PSE : une nouvelle technologie a le potentiel de transformer la fabrication des produits pharmaceutiques
LONDRES--(BUSINESS WIRE)--Pfizer, l'entreprise pharmaceutique de premier plan, a exposé sa vision pour Systems-based PharmaceuticsTM, une approche révolutionnaire basée sur un modèle liant le procédé de fabrication d'un médicament et l'ingénierie de produit à la qualité et à la performance du produit dans le corps humain, à l'occasion du récent forum sur la modélisation avancée des procédés organisé à Londres. Le conférencier d’honneur Ravi Shanker, chargé de recherche principal chez Pfizer, a d

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


PSE: Neue Technologie hat Potenzial, die Pharma-Herstellung zu transformieren
LONDON--(BUSINESS WIRE)--Das führende Pharma-Unternehmen Pfizer umriss auf dem Advanced Process Modelling Forum, das vor Kurzem in London stattfand, seine Vision systembasierter Pharmazeutika. Systems-based PharmaceuticsTM ist ein revolutionärer, modellbasierter Ansatz, der Produktverfahren und Fertigungstechnik mit der Qualität des Produkts und dessen Leistung im menschlichen Körper verbindet. Ravi Shanker, Senior Research Fellow bei Pfizer und ein Hauptredner des Forums, sagte, es sei für die

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Riassunto: PSE: una nuova tecnologia dispone del potenziale per trasformare la produzione farmaceutica
LONDRA--(BUSINESS WIRE)--L'importante casa farmaceutica Pfizer ha delineato la propria visione sulla Systems-based PharmaceuticsTM, un rivoluzionario approccio basato sui modelli che mette in correlazione i processi farmacologici e l'ingegneria dei prodotti con la loro qualità e gli effetti biologici sul corpo umano, in occasione del recente Advanced Process Modelling Forum di Londra. Ravi Shanker, responsabile senior della ricerca presso Pfizer e oratore principale dell'evento, ha dichiarato ch

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Comcast estrecha la conexión entre familiares y amigos con el lanzamiento de Skype en Xfinity
FILADELFIA--(BUSINESS WIRE)--Comcast anunció hoy que Skype™ ya está disponible en Xfinity®, una nueva experiencia de videollamadas con pantalla panorámica de alta definición (HD por sus siglas en inglés), en Boston y Seattle como resultado del comienzo del lanzamiento del servicio a nivel nacional. Antes del fin de semana, el servicio también estará disponible en las siguientes áreas metropolitanas: Atlanta, Augusta, Georgia; Chicago; Detroit; Harrisburg, Pensilvania; Indianápolis; Miami; y Pitt

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Le sommet mondial de la maison numérique est fier de présenter le meilleur panel d'intervenants jamais vu
LONDRES--(BUSINESS WIRE)--Informa Telecoms & Media, organisateurs du sommet mondial 2012 de la maison numérique, principal événement du secteur axé sur la maison et les zones avoisinantes connectées, a annoncé aujourd'hui son meilleur panel d'intervenants de tous les temps. Le sommet, qui s'enorgueillit de plus de 50 conférenciers de classe internationale venus de 21 pays, présente un panorama vraiment mondial de la maison numérique, avec plus d'intervenants de premier ordre que n'importe qu

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Avtex Achieves Four Gold, Six Silver Competencies in Microsoft Partner Network
MINNEAPOLIS--(BUSINESS WIRE)--Avtex, a provider of integrated interaction solutions, announced today it has attained a total of 10 competencies in the Microsoft Partner Network. The combination of four gold and six silver competencies demonstrates Avtex’s unique blend of both breadth and depth within the Microsoft partner program. To earn a Microsoft Gold or Silver Competency, a partner must prove their level of technology expertise by successfully completing certification exams, submit customer

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


90 Million Homes Worldwide Will Employ Home Automation Systems by 2017, Finds ABI Research
LONDON--(BUSINESS WIRE)--New subscription-based home automation offerings are rapidly transforming the way consumers will monitor, secure, and control their homes. Long the preserve of more expensive, custom-installed technology, home automation is moving into the mainstream, with companies such as ADT, Comcast, Verizon, Lowe’s, and many others all adding home automation to their customer services. A number of factors are driving the new entrants into the market. Connectivity is one key factor.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


ProcureStaff Technologies Selected as an American Business Awards(SM) Finalist
NEW YORK--(BUSINESS WIRE)--ProcureStaff Technologies, leading provider of the Consol Vendor Management System (VMS), has been named a finalist in the 2012 American Business Awards (ABA) “Support Department of the Year” category. The Consol Support Team was selected for implementing a continuous process improvement initiative that includes annual proactive quality and configuration reviews to help clients optimize Consol’s new, existing and evolving features. “Being named an ABA finalist acknowle

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


PSE: New Technology Has Potential to Transform Pharma Manufacture
LONDON--(BUSINESS WIRE)--Leading pharmaceuticals company Pfizer outlined its vision for Systems-based Pharmaceutics at the recent Advanced Process Modelling Forum in London organised by Process Systems Enterprise (PSE)

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Comcast Brings Family and Friends Closer Together with the Launch of Skype on Xfinity
PHILADELPHIA--(BUSINESS WIRE)--Comcast Brings Family and Friends Closer Together with the Launch of Skype on Xfinity, Enables Customers to Use Big-Screen HD Televisions and Internet Connections to Make and Receive Skype Calls

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Interxion Executive to Present at Upcoming Conferences
AMSTERDAM--(BUSINESS WIRE)--Interxion Holding N.V. (NYSE: INXN), a leading European provider of carrier neutral colocation data centre services, announced today that CFO Josh Joshi is scheduled to speak at Barclays Capital’s Global Technology, Media and Telecommunications Conference on Wednesday, May 23 from 11:15 a.m. - 11:40 a.m. Interested parties can listen to the session via a live webcast at https://barclays-r1.alldigital.net/viewer/login/gtmtc/247. At the conclusion of the conference, the

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Resumen: EVault obtiene una puntuación de 5 estrellas en la Guía de programas colaboradores de CRN por segundo año consecutivo
SAN FRANCISCO--(BUSINESS WIRE)--EVault, Inc., empresa perteneciente a Seagate Company (NASDAQ:STX), ha anunciado hoy que su programa CCSP (Cloud-Connected Service Provider) ha sido clasificado como Colaborador 5 estrellas en la Guía de los programas colaboradores de CRN por segundo año consecutivo. El presidente y director general de EVault, Terry Cunningham, ha obtenido el reconocimiento de director de canal CRN por segundo año consecutivo. El comunicado en el idioma original, es la versión ofi

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Samenvatting: Scytl onthult veilig online stemmen op Google Android en Apple iOS apparaten
BALTIMORE--(BUSINESS WIRE)--Scytl, wereldwijd marktleider op het gebied van software gebruikt voor verkiezingen, heeft met succes zijn online stemversleutelingstechnologie geïmplementeerd voor het gebruik op Google Android en Apple iOS smartphones en tablet computers. De stemkeuze van de kiezer wordt versleuteld op zijn mobiele apparaat voordat hij zijn stem uitbrengt. Hiermee garandeert Scytl volledige beveiliging - vanaf het moment waarop de kiezer zijn keuze maakt tot het uitbrengen van zijn

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Embarcadero Announces Support for Windows 8 Metro Development with Release of Embarcadero Prism XE2.5
SAN FRANCISCO--(BUSINESS WIRE)--Embarcadero today announced Prism XE2.5, which extends the reach of software developers with support for both Windows 8 and Metro and supports the beta of Microsoft Visual Studio 11.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Innovaro’s LaunchPad Can Now Mine Google+, PST Files and LinkedIn
TAMPA, Fla.--(BUSINESS WIRE)--Innovaro, Inc. (NYSE MKT: INV), The Innovation Solutions Company is excited to announce that LaunchPad's SemBots can now mine Google+, Microsoft Exchange PST Files and LinkedIn. These additions further enhance LaunchPad's already robust capabilities to upload and analyze corporate data, social media and other information sources. User specified information can now be automatically extracted from Google+, PST Files and LinkedIn. The resulting data points are then aut

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Research and Markets: Future Growth Potential of Mobile Money in India: Market Profile
DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/zhflr4/future_growth_pote) has announced the addition of the "Future Growth Potential of Mobile Money in India: Market Profile" report to their offering. The report provides top-level market analysis, information and insights, including: - In-depth analysis of mobile money opportunities in India - A comprehensive and country-specific analysis of market attractiveness, covering the key trends, drive

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Samenvatting: Digital Home World Summit maakt lijst van sprekers bekend
LONDON--(BUSINESS WIRE)--Informa Telecoms & Media, de organisatoren van de Digital Home World Summit 2012 hebben de sprekerslijst bekendgemaakt. Op de top zijn 50 belangrijke spelers uit 21 landen aanwezig waaronder: Telmo Perez, VP, Home Line of Business bij France Telecom, Marco Romero Rodriguez, Head of Sustainability & Energy Efficiency bij Telefonica en Renaud Di Francesco, Divisional Director Europe Technology Standards Office bij SONY. Op dag 2 vindt de introductie plaats van de g

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Cbeyond Cloud and Network Solution Streamlines IT Infrastructure for Pro Access Systems
ATLANTA--(BUSINESS WIRE)--Cbeyond, Inc. (NASDAQ: CBEY), a leading provider of network and cloud services to small and medium sized businesses, today announced that it has been selected by Pro Access Systems, a leading provider of perimeter security solutions including access control, gates, operators and hardware, to provide a customized voice, enterprise-class data and secure cloud services package that will enhance the company’s efficiency and communication across its partner and business netw

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


SABIC Vice Chairman and CEO attends 16th annual Microsoft CEO Summit
RIYADH, Saudi Arabia--(BUSINESS WIRE)--Taking the opportunity to discuss business challenges and share insights with peers from around the globe, Mohamed Al-Mady, vice chairman and CEO of the Saudi Basic Industries Corporation (SABIC), joined 100 of the world’s most influential business leaders at the 16th annual Microsoft CEO Summit in Seattle, on May 16. Al-Mady’s interactions with fellow CEOs helped to build professional and personal relations and deeper understandings of evolving needs in va

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Tenable Network Security Named Top ‘Cyber Warrior’ at Baltimore SmartCEO VOLT Awards
COLUMBIA, Md.--(BUSINESS WIRE)--Tenable Network Security was recently named top ‘Cyber Warrior’ at Baltimore SmartCEO VOLT Awards. This award highlights Tenable’s cybersecurity innovation, leadership, and global economic success.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Confluence Webinar Explores the Growing Complexity of Reporting for Fund Administrators in Europe – AIFMD, Multi-Regional Processing, and More
PITTSBURGH--(BUSINESS WIRE)--Confluence, the leading provider of automated data management solutions for the investment management industry, today announced a new webinar that will address ways to leverage multi-regional processing models, the scope and scale of The Alternative Investments Funds Market Directive (AIFMD), how fund valuation changes will impact the function and responsibilities of the fund administrator, and more. The complimentary webinar entitled "European Regulation and the Gro

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Insperity Raises Quarterly Dividend 13%
HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced that its board of directors has approved an increase in its quarterly cash dividend to $0.17 per share. The cash dividend – representing an increase of $0.02 per share over the prior quarter – will be paid on June 22, 2012, to all stockholders of record as of June 1, 2012. Insperity, a trusted advisor to America's best busi

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


DPD International Partners with etherFAX to Extend GoldFax Enterprise Fax Solutions to the Cloud
MARLBORO, N.J.--(BUSINESS WIRE)--etherFAX announces partnership with DPD International, makers of GoldFax™. GoldFax will utilize etherFAX® to cloud-enable the company’s GoldFax for Windows® software.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Research and Markets: IBM Global Services - SWOT Framework Analysis
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/56s52l/ibm_global_service) has announced the addition of the "IBM Global Services - SWOT Framework Analysis" company profile to their offering. SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and identifying the internal an

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Resumen: Digital River anuncia resultados de encuesta internacional de comercio
MINEÁPOLIS--(BUSINESS WIRE)--Digital River, Inc. (NASDAQ: DRIV), los expertos en crecimiento de ingresos del comercio internacional en la nube, han anunciado hoy, durante la conferencia de comercio Digital River® Globalocity TM que ha tenido lugar en Los Ángeles, California, los resultados de una encuesta realizada a 250 ejecutivos senior de empresas del mercado del software, juegos y electrónica de consumo. La encuesta preguntó a las empresas cuáles eran sus planes comerciales para expandirse h

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


athenahealth Announces Winners of Health 2.0 Code-a-thon and Kicks-off More Disruption Please Program
WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups, today announced the winners of Health 2.0’s Boston Big Data Code-a-thon event, which was hosted at athenahealth’s headquarters in Watertown, Massachusetts, on Saturday, May 12. More than 100 participants attended the event conducted in partnership with Health 2.0 and in conjunction with AT&am

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


There’s Something New at the Zoo! Houghton Mifflin Harcourt’s Popular Mobile App for Preschoolers Curious George® at the Zoo Introduces New “Deep Freeze” Habitat
BOSTON--(BUSINESS WIRE)--Global education leader Houghton Mifflin Harcourt (HMH) today announced a new addition to its popular Curious George® at the Zoo app with the Deep Freeze habitat, which introduces preschoolers to an Arctic environment. The app, which has received rave reviews and climbed app charts around the world since its release in early April, reached over half a million downloads in its first ten days in the App StoreSM. The addition of the Deep Freeze region pack gives players acc

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


[Nachträglicher Bericht] Ausstellung der asiatischen Photonik- und Laserbranche: Photonix 2012
TOKIO--(BUSINESS WIRE)--Die Photonix 2012, die Ausstellung der asiatischen Photonikbranche, hat vom 11. bis 13. April in Tokio stattgefunden.In Bereichen wie Kommunikationstechnologien, Fotovoltaik, Sekundärbatterien und Elektronik, bei denen immer häufiger Laser- und Optiktechnologien angewendet werden, wird der japanische und allgemein der asiatische Markt immer wichtiger. Die globale Photonikbranche zählt Asien mittlerweile zu den Schwerpunktregionen, wodurch die Photonix zu einer größeren un

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Aquilent Recognized Once Again as One of Top 50 Best Places to Work in Greater Washington by the Washington Business Journal
LAUREL, Md.--(BUSINESS WIRE)--Aquilent today announced that it has been recognized for a third year as one of the Top 50 Best Places to Work in Greater Washington by the Washington Business Journal

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Orbit International to Present at the B. Riley & Co. 13th Annual Investor Conference on Tuesday, May 22nd
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Orbit International Corp. (NASDAQ:ORBT) today announced that its President & CEO, Mitchell Binder will present at the B. Riley & Co. 13th Annual Investor Conference, on Tuesday, May 22, 2012 at 10:00 am PT at the Loews Santa Monica Beach Hotel in Southern California. Investors will be able to download the PowerPoint Presentation from the Investor Relations section of Orbit’s website, www.orbitintl.com. Orbit International Corp. is involved in the manufac

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Numerix Introduces New Instrument Coverage and Usability Features in LiquidAsset 2.0
NEW YORK--(BUSINESS WIRE)--Numerix (www.numerix.com), the leading provider of cross-asset analytics for derivatives valuations and risk management, announced today the release of Numerix LiquidAsset 2.0, an easy-to-use, rapidly deployable solution to price the most common set of liquid OTC derivatives. Built on Numerix CrossAsset, the industry’s leading pricing analytics platform, LiquidAsset is available on the desktop through Microsoft Excel, or can be integrated into proprietary or third-part

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Life is good Leverages Demandware to Spread the Power of Optimism in the Digital Space
BURLINGTON, Mass.--(BUSINESS WIRE)--Life is good selects Demandware as a platform to support its digital growth strategy.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Zix Corporation Enhances ZixPort with Message Recall and Two-Factor Authentication
DALLAS--(BUSINESS WIRE)--New ZixPort features increase control and flexibility for compliance and security officers.

Add to Facebook Add to Twitter Add to del.icio.us Add to Reddit Add to digg Add to StumbleUpon Email this Article


Microsoft teams up with Telefónica to support tech startups
Microsoft has agreed to provide tools, knowledge and technical training for projects supported by Wayra, Telefónica’s accelerator programme for technology startups.




OpenStack may be gaining support from IBM but Iaas is still making slow headway
When it comes to Infrastructure as a Service - renting on-demand compute, storage and network resources that live in a multi-tenant virtualised public cloud - midsized businesses are jumping in with both feet. But large enterprises with their own well-established data centres are still dipping their toes in the water.


OpenStack may be gaining support from IBM but Iaas is still making slow headway
When it comes to Infrastructure as a Service - renting on-demand compute, storage and network resources that live in a multi-tenant virtualised public cloud - midsized businesses are jumping in with both feet. But large enterprises with their own well-established data centres are still dipping their toes in the water.




Los Angeles County Uses Analytics to Stop Child-Care Fraud


Digital Billboards to Alert Texas Counties in Emergencies


Is Government Moving Fast Enough on Mobility and Apps? (VIDEO)


Corruption Probe Snares Two in Wayne County, Mich.


Utah CIO Steve Fletcher Resigns, State Promises Security Reforms


Can Twitter and Facebook Transform 311? (VIDEO)


Free Tool Gauges Website Engagement Effectiveness


Texas DMV Gets Major Tech Upgrade


Kansas Business Startups Get Help Online


New Hampshire Law Promotes Open Source Software (VIDEO)


Roche's Genentech to Take Part in First-ever Alzheimer's Prevention Trial
Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such trial to gauge whether early intervention can help prevent or slow the disease. The drug will be tested among members of an extended family of about 5,000 people from the Antioquia region of Colombia. They carry a gene that causes them to develop...

Pfizer Inc. Cuts 50 Jobs at Estrogen Facility
Drugmaker Pfizer's restructuring of its estrogen extraction plant at Brandon, Man. calls for about 40 per cent fewer employees by the end of next year. The company processes conjugated estrogen from pregnant mares' urine (PMU) at Brandon to make the hormone replacement therapy Premarin, used to treat menopausal symptoms in women. Pfizer said Tuesday it plans to cut about 50 of 130 positions at the...

Pfizer Inc.'s Torisel Fails Phase III Renal Cell Carcinoma Study in Showdown Against Bayer HealthCare's Nexavar
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib. Although PFS was numerically...

Two-Drug Combo Helps Teens With Migraines, GlaxoSmithKline Reveals
A two-drug combination that relieves migraines in adults also works well in adolescents, new research indicates. Although the findings basically support what doctors are already doing, "it is nice to have this officially shown in a study in adolescents," said Dr. Ellen Drexler, associate director of neurology at Maimonides Medical Center in New York City.

Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer Inc., AstraZeneca PLC, Sanofi (France)
Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc. (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the drugmakers sale process, said people familiar with the matter. Merck & Co., Takeda Pharmaceutical Co., Roche Holding AG (ROG) and Bristol-Myers Squibb Co. (BMY) also signed agreements to get access to confidential financial and product information...

GlaxoSmithKline to Fully Buy Cellzome AG for $99 Million
Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSK.LN) said Tuesday it has entered into an agreement to buy the 80.02% of Cellzome AG it doesn't already own for GBP61 million in cash. Cellzome, a privately owned company with laboratories in Cambridge, U.K., and Heidelberg, Germany, will become part of GSK's R&D organization. Cellzome's proteomics technologies can be used...

How Payers View Pfizer Inc.'s Rheumatoid Arthritis Pill
An FDA panel may have recommended a new Pfizer pill for rheumatoid arthritis last week, but of course, the drugmaker must still win over regulators, doctors and payers. And while Wall Street is betting the FDA will approve tofacitinib, convincing payers of its worth may prove more difficult. Although pricing will be a major determinant in coverage, it is clearly not the only factor. How so? A new survey...

Going, Going, Gone. Pfizer Inc. Eliminates Pensions
First, Pfizer recently told employees that severance packages would be reduced as of mid-May. Now, the big drugmaker plans to eliminate its defined benefit pension plan as of 2018 and will direct employees to funnel their money into a 401K investment account, according to a company memo. And the pending changes will apply to all employees, including the c-suite crowd, a Pfizer spokeswoman tells us...

Opko Health, Inc. Catches Investors' Attention With Alzheimer's Test
As Pfizers rheumatoid arthritis pill and Arena Pharmaceuticals weight-loss drug got positive nods from federal advisory panels, the role of biotech companies in finding new treatments for major medical disorders is getting renewed investor attention. An advisory group at the Food and Drug Administration recommended approval of Pfizers drug, known as tofacitinib, which could possibly revive sales...

Red Wine Compound Can Combat Alzheimer???s, Georgetown University Medical Center Study
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study....

Google Inc.'s Makes Strides in Hunt for Parkinson's Cure Through Unique Pact With Pfizer Inc., GlaxoSmithKline
Sergey Brin, the 38-year-old co- founder of Google Inc. (GOOG), is making strides in his quest to find a cure for Parkinsons, a progressive disease his DNA and family history suggest may afflict him as early as 10 years from now. The advances are encouraging Pfizer Inc. (PFE) and GlaxoSmithKline Plc (GSK) to pursue a new class of medicines that may become the first to slow the progress of Parkinson...

FDA Advisers Back Pfizer Inc. Arthritis Drug
A federal advisory panel recommended approval on Wednesday of a rheumatoid arthritis pill that could offer patients an alternative to the injectable medicines already on the market, but several members expressed concern about safety and urged the Food and Drug Administration to require rigorous follow-up studies. The arthritis advisory committee voted 8 to 2 that the drug, known as tofacitinib, offered...

Eli Lilly and Company and Abbott Laboratories Win Big in Sales Rep Overtime Case
In a decision that bolsters the pharmaceutical industry, a federal appeals court has ruled that sales reps are not eligible for overtime pay. In doing so, the court also rejected the position taken by the US Department of Labor, which has filed briefs in numerous cases supporting the notion that sales reps are entitled to overtime. The ruling by the Seventh Circuit Court of Appeals combined cases involving...

Lipitor Clone Lifts Ranbaxy Laboratories While Pfizer Inc. Bids Drug Goodbye
Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the same time, generic drug manufacturer Ranbaxy posted record revenue for the last business quarter, growth fueled largely by sales of generic atorvastatin in the United States.

GlaxoSmithKline: We Complied With Indian Rules for Drug Approval
Indias top drug regulatory agency violated laws and colluded with pharmaceutical companies to approve medicines without clinical trials, a parliamentary panel said in a report. The Central Drugs Standard Control Organization which oversees clinical trials and Indias 10,000 drugmakers, approved medicines from companies including Novartis AG (NOVN), GlaxoSmithKline Plc (GSK) and Mumbai-based Cipla...

GlaxoSmithKline's $2.6 Billion Bid for Human Genome Sciences, Inc. Goes Hostile
GlaxoSmithKline will take its $2.6 billion bid for Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the U.S. biotech group's board. The decision to go hostile with the $13 a share cash tender offer sets GSK up for a potentially lengthy battle with those Human Genome investors who believe it is not offering enough. "They will do fantastically...

Rollin’ Out

MARIETTA, Ga., May 16, 2012 – A future C-5M rolled out of the hangar at the Lockheed Martin [NYSE: LMT] facilities here, May 10. Tail number 87-0045 received new engine pylons and wiring, and will now be fitted with new, state-of-the-art GE F138-GE-100 turbofan engines and undergo flight checks before being delivered to Dover Air Force Base, Del., later this year.  


Lockheed Martin Orbits 100th and 101st Commercial Geo Satellites With Successful Launch of JCSAT-13 And VINASAT-2

KOUROU, French Guiana, May 15, 2012 – The 100th and 101st Lockheed Martin [NYSE: LMT] commercial geostationary communication satellites have been successfully placed in orbit today after a dual launch aboard an Ariane 5-ECA launch vehicle.  Both satellites are based on Lockheed Martin’s A2100 geosynchronous satellite series.   


A Dozen Lockheed Martin F-35s Now Call Eglin AFB Home

FORT WORTH, Texas, May 15, 2012 – The twelfth Lockheed Martin [NYSE: LMT] F-35 Lightning II destined for the training fleet at Eglin Air Force Base, Fla., was ferried today. U.S. Marine Corps pilot Lt. Col. Fred Schenk piloted the aircraft, known as BF-11, which departed Naval Air Station Fort Worth Joint Reserve Base, Texas at 10:02 a.m. CDT for an approximate 90-minute flight to Florida’s Emerald Coast.


Lockheed Martin’s Second Generation Aegis Ballistic Missile Defense System Successfully Intercepts Missile

First ballistic missile intercept for second-generation of Aegis BMD

KAUAI, Hawaii, May 14, 2012 – The Missile Defense Agency (MDA), U.S. Navy and Lockheed Martin [NYSE: LMT] team successfully intercepted a ballistic missile target for the first time, using the second generation of the Aegis Ballistic Missile Defense (BMD) system, known as Aegis BMD 4.0.1.


Lockheed Martin’s New Standalone Launching System Significantly Reduces Weapons Integration Costs

CANBERRA, Australia, May 14, 2012 – Lockheed Martin [NYSE: LMT] successfully demonstrated the latest variant of its new launching system that maximizes the use of existing hardware and electronics to reduce the integration costs of weapons by more than 50 percent.


Two Lockheed Martin F-35Bs Ferried To Eglin, Marking 25th DOD Delivery

FORT WORTH, Texas, May 10, 2012 – Two Lockheed Martin [NYSE: LMT] F-35B short takeoff/vertical landing (STOVL) production aircraft were ferried to Eglin Air Force Base, Fla., today, marking the 24th and 25th F-35 deliveries to the Department of Defense. The 5th Generation multirole fighter jets were delivered to the United States Marine Corps and are now assigned to the 2nd Marine Aircraft Wing’s Marine Fighter/Attack Squadron 501 residing with the host 33d Fighter Wing.


First Travis C-5B Inducted

MARIETTA, Ga., May 9, 2012 – Lockheed Martin [NYSE: LMT] last week inducted into its facilities here the first C-5B Galaxy from Travis Air Force Base, Calif., to become a  C-5M Super Galaxy.


Lockheed Martin Completes Delivery Of 17 CC-130J Super Hercules Aircraft To Canada

MARIETTA, Ga., May 8, 2012 – The Royal Canadian Air Force formally accepted the 17th Lockheed Martin [NYSE: LMT] CC-130J Super Hercules in ceremonies here today, completing the order placed in December 2007. The aircraft will be flown to Canadian Forces Base Trenton later this week.


Lockheed Martin Wins Role on Department of Homeland Security Communications Program

The U.S. Department of Homeland Security (DHS) has selected Lockheed Martin [NYSE: LMT] to compete for future task orders through its new Tactical Communications (TACCOM) program.  Among 30 awardees, Lockheed Martin was one of five to be selected to compete for TACCOM tasks in all five of the program’s core areas. 


Second Advanced EHF Military Communications Satellite Built By Lockheed Martin Launched Successfully for the U.S. Air Force

CAPE CANAVERAL AIR FORCE STATION, Fla., May 4, 2012 – The second Advanced Extremely High Frequency (AEHF-2) military communication satellite, built by a Lockheed Martin [NYSE: LMT] team for the U.S. Air Force, was successfully launched today from Cape Canaveral Air Force Station aboard a United Launch Alliance (ULA) Atlas V rocket.


Lockheed Martin to Assist Department of Defense in Fight Against Growing Threat: Cyber Crime

Supporting DoD’s Cyber Crime Center through Digital Forensics and Analysis


Lockheed Martin Delivers Final, Historic F-22 Raptor To U.S. Air Force

MARIETTA, Ga., May 2, 2012 – Lockheed Martin [NYSE: LMT] leadership delivered today the 195th and last F-22 Raptor to U.S. Air Force leadership in a ceremony at the Lockheed Martin Aeronautics site here. With this delivery, the U.S. Air Force now possesses the world’s only 5th generation stealth fighter aircraft fleet in the world.


Lockheed Martin Completes GOES-R Weather Satellite Critical Design Review

DENVER, May 1, 2012 – The Lockheed Martin [NYSC: LMT] team developing NASA and NOAA’s Geostationary Operational Environmental Satellite-R series (GOES-R) satellite has successfully completed the spacecraft Critical Design Review (CDR), a major milestone that paves the way for the production of the nation’s next-generation geostationary weather satellite system.


Press Releases
  December 6, 2011 Convergence Technology Consulting named a 2012 SmartCEO Magazine Future 5...


Warning: DOMDocument::load(http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.rss) [domdocument.load]: failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/techcncl/techcouncilmd.com/news/index.php on line 181

Warning: DOMDocument::load() [domdocument.load]: I/O warning : failed to load external entity "http://www.lifetechnologies.com/content/lifetech/en/home/rss/press-releases.rss" in /home/techcncl/techcouncilmd.com/news/index.php on line 181
New National Bioeconomy Blueprint Can Help Unleash the Promise of Biotech to Drive American Innovation, Promote Job Growth and Continue U.S. Competitiveness
WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Obama Administration's new National Bioeconomy Blueprint issued today: “BIO applauds President Obama’s leadership in creating a National Bioeconomy Blueprint and identifying the bioeconomy as a priority for his Administration. We appreciate the President’s recognition of the need to clear the path for American innovation and ingenuity and unleash t


Senator Bob Menendez Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Senator Robert Menendez (D-NJ) as a Legislator of the Year for 2011-2012.


Representative Rogers Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Mike Rogers (R-MI) as a Legislator of the Year for 2011-2012.


Representative Kingston Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Jack Kingston (R-GA) as a Legislator of the Year for 2011-2012.


Representative Schwartz Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Representative Allyson Schwartz (D-PA) as a Legislator of the Year for 2011-2012.


Senator Enzi Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announced today its selection of Senator Michael Enzi (R-WY) as a Legislator of the Year.


Senator Hagan Honored as BIO Legislator of the Year
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization selected Senator Kay Hagan (D-NC) as a Legislator of the Year for 2011-2012.


BIO Announces Governor Jon Huntsman as Keynote Speaker for the BIO Convention in China
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announces that Governor Jon Huntsman, former U.S. Ambassador to China and Governor of Utah, will provide a keynote address at the BIO Convention in China.


Leaders in Science, Advocacy to Judge 2012 Biotech Humanitarian Award
WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announced a distinguished panel of judges who will evaluate nominations for the fourth annual Biotech Humanitarian Award and select the 2012 Honoree. BIO created the Award to recognize an everyday hero who has helped to heal, fuel and feed the planet through their work in or support of biotechnology. Nominations for the Award will be accepted online through the April 20, 2012 deadline. “The Biotech Humanitarian Awa


BIO Submits Comments on FDA Draft Guidances on Biosimilars
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products.


Follow